Development of personalized cancer immunotherapy
Location: United States
Total raised: $10M
Investors 3
| Date | Name | Website |
| - | Korea Inve... | partners.k... |
| 06.04.2022 | Flerie Inv... | flerie.com |
| - | 3B Future ... | 3bfuturehe... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 05.10.2023 | - | $5M | - |
| 12.04.2023 | - | $5M | - |
Mentions in press and media 11
| Date | Title | Description |
| 05.10.2023 | Geneos Therapeutics: Clinical-Stage Biotherapeutics Company Secures $5 Million | Geneos Therapeutics – a clinical-stage biotherapeutics company focused on developing personalized therapeutic cancer vaccines (PTCV) – recently announced that it has completed its Series A3 financing round with an additional investment of $... |
| 28.09.2023 | Geneos Therapeutics Closes $5M Series A3 Financing | Geneos Therapeutics, a Plymouth Meeting, PA-based clinical stage biotherapeutics company, raised $5M in Series A 3 funding. The round, which brought the total amount to $10M, saw participation form Shanghai Healthcare Capital. Dr. Jing Bao,... |
| 12.04.2023 | Geneos Therapeutics Raises $5M in Series A3 Financing | Geneos Therapeutics, a Plymouth Meeting, PA-based clinical stage biotherapeutics company, raised $5M in Series A3 funding. This financing adds 3B Future Health Fund (3B FHF) to Geneos’ investor syndicate. Further, Dr. Roberto DePonti, manag... |
| 25.03.2022 | Geneos Therapeutics Raises $17M in Series A2 Funding | Geneos Therapeutics, a Plymouth Meeting, PA-based clinical stage biotherapeutics company, raised $17M in Series A2 funding. The round was led by Flerie Invest with participation from Santé Ventures, Korea Investment Partners, Global Bio Fun... |
| 16.03.2021 | VGXI and Geneos Therapeutics Expand Partnership for Personalized Cancer Immunotherapies | The renewed agreement is a testament to the experience and capabilities of the VGXI team in meeting the challenging requirements of this project. THE WOODLANDS, Texas (PRWEB) March 16, 2021 VGXI, Inc., an industry leading manufacturer for p... |
| 08.03.2021 | Geneos Therapeutics Raises $12M in Series A1 Financing | Geneos Therapeutics, a Plymouth Meeting, Pa.-based clinical stage company focused on the development of tumor neoantigen targeted personalized immunotherapies for cancer, closed its Series A1 round, raising $12m in financing. The round was ... |
| 22.02.2019 | Term Sheet — Friday, February 22 | THREE THINGS Happy Friday, Term Sheet readers. Paid Content Securing the enterprise without boundaries From ExtraHop The deal values the startup at $7.1 billion, which puts DoorDash right on the heels of its closest rival Grubhub, whose mar... |
| 21.02.2019 | Geneos Therapeutics Secures $10.5M in Series A Financing | Geneos Therapeutics, a Plymouth Meeting, Pa.-based developer of neoantigen-targeting cancer immunotherapies, closed its Series A round raising $10.5M. The round was led by Santé Ventures, joined by Inovio. The company intends to use the fun... |
| 21.02.2019 | Geneos Therapeutics Receives $10.5M Series A | PLYMOUTH MEETING, PA, Geneos Therapeutics announced today that it has closed its Series A round raising $10.5 Million in financing. >> Click here for more funding data on Geneos Therapeutics >> To export Geneos Therapeutics ... |
| 21.02.2019 | Top startup news for today, Thursday, February 21, 2019 | Good morning! Here are some of the top technology startup news stories for today, Thursday, February 21. Better.com receives $5 million additional Funding from Citigroup to continue to expand operations and its business reach. We wrote abo... |
Show more